Galmed Pharmaceuticals Ltd. (EOCN): Shareholders' Equity
$15.78M
As of 2025-12-31
+5.5%
3-year compound annual growth
-18.6%
5-year compound annual growth
-3.1%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $15.78M | -3.3% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $16.33M | +17.6% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $13.88M | +3.4% | 2026-03-31, Balance as of period end |
| 2022-12-31 | $13.42M | -56.0% | 2025-04-02, Balance as of period end |
| 2021-12-31 | $30.50M | -30.9% | 2024-04-04, Balance as of period end |
| 2020-12-31 | $44.15M | -36.8% | 2023-03-29, Balance as of period end |
| 2019-12-31 | $69.85M | -20.5% | 2022-05-02, Balance as of period end |
| 2018-12-31 | $87.89M | +456.5% | 2021-03-18, Balance as of period end |
| 2017-12-31 | $15.79M | +42.6% | 2020-03-12, Balance as of period end |
| 2016-12-31 | $11.07M | -48.6% | 2019-03-13, Balance as of period end |
| 2015-12-31 | $21.55M | -31.4% | 2018-03-13, Balance as of period end |
| 2014-12-31 | $31.41M | n/m | 2017-03-23, Balance as of period end |
| 2013-12-31 | -$1.95M | n/m | 2016-03-22, Balance as of period end |
| 2012-12-31 | -$1.98M | n/a | 2015-03-31, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. (EOCN) | 2025-12-31 | $15.78M | -3.3% |
| Lite Strategy, Inc. (LITS) | 2025-06-30 | $16.93M | -48.7% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $9.83M | -16.8% |
| Genelux Corp (GNLX) | 2025-12-31 | $11.54M | -56.1% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $16.80M | -9.5% |
| Clene Inc. (CLNN) | 2025-12-31 | -$17.59M | n/m |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $12.63M | n/a |
| Galectin Therapeutics Inc (GALT) | 2025-12-31 | -$127.92M | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $14.86M | -49.8% |
Compare EOCN, LITS, ALLR, GNLX side by side · Screen every company in Pharmaceutical Preparations ↗